EUVIMEDEUVIMED entdecken
Crossref

Serum fibroblast growth factor 23 concentration and the risk of mortality in patients undergoing peritoneal dialysis

Zhong Zhong iD, Shaozhen Feng, Dongying Fu, Bin Li, Zhijian Li, Haiping Mao

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · 2024

DOI: 10.1177/08968608241231697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 2024. Verfasst von Zhong Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Fibroblast Growth Factors, Kidney Failure, Chronic, Peritoneal Dialysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fibroblast growth factor 23 (FGF23) is a phosphate-regulating hormone that is secreted in large amounts early in chronic kidney disease. In this cohort, we aimed to investigate the association between serum FGF23 concentration and mortality in patients undergoing peritoneal dialysis (PD).

Methods

Serum FGF23 level was determined by enzyme-linked immunosorbent assay (ELISA) in a large 15-year prospective cohort study of PD patients with stored serum samples at baseline. Kaplan–Meier survival curves and Cox proportional hazards models were performed to characterise the relationship of FGF23 with mortality.

Results

A total of 737 incident PD patients were analysed. The baseline median FGF23 concentration was 683.2 (518.5–896.2) pg/mL. Age, serum phosphorus, high-density lipoprotein cholesterol and high-sensitivity C-reactive protein were independently correlated with serum FGF23 concentration. During a median follow-up of 66.7 (41.1–95.4) months, 171 of the 737 participants (23.2%) died, including 84 (49.1%) cardiovascular disease-related and 50 (29.2%) infection-related deaths. Multivariable Cox regression analysis showed that the adjusted hazard ratios of the highest tertile of serum FGF23 compared with those in the lowest tertile were 1.36 (95% confidence interval (CI): 0.89–2.07; p = 0.154), 0.75 (95% CI: 0.40–1.38; p = 0.353) and 2.66 (95% CI: 1.15–6.15; p = 0.022) for all-cause, cardiovascular disease-related and infection-related mortality, respectively.

Conclusion

High serum FGF23 concentration is associated with a higher risk of infection-related death for incident PD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth Factor-23Fibroblast Growth FactorsKidney Failure, ChronicPeritoneal DialysisAdultFemaleHumansMaleMiddle AgedCardiovascular DiseasesCohort StudiesEnzyme-Linked Immunosorbent AssayKaplan-Meier EstimateProportional Hazards ModelsProspective StudiesRisk Assessment

Stichwörter der Autor:innen

Cohort studyfibroblast growth factor 23mortalityperitoneal dialysis

Substanzen

FGF23 protein, humanFibroblast Growth Factor-23Fibroblast Growth Factors

Autor:innen und Institutionen

  • Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China.
  • Zhong Zhong and Shaozhen Feng contributed equally to this manuscript.
  • Clinical Trials Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Zhong Zhong

Zitieren

APA

Zhong, Z., Feng, S., Fu, D., Li, B., Li, Z., & Mao, H. (2024). Serum fibroblast growth factor 23 concentration and the risk of mortality in patients undergoing peritoneal dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. https://doi.org/10.1177/08968608241231697

Vancouver

Zhong Z, Feng S, Fu D, Li B, Li Z, Mao H. Serum fibroblast growth factor 23 concentration and the risk of mortality in patients undergoing peritoneal dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 2024. doi:10.1177/08968608241231697

BibTeX
@article{Zhong2024,
  author = {Zhong, Zhong and Feng, Shaozhen and Fu, Dongying and Li, Bin and Li, Zhijian and Mao, Haiping},
  title = {Serum fibroblast growth factor 23 concentration and the risk of mortality in patients undergoing peritoneal dialysis},
  journal = {Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis},
  year = {2024},
  doi = {10.1177/08968608241231697}
}
Kostenlos starten →